|
| Press Releases |
|
 |
|
| Tuesday, August 23, 2022 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the "Period"). more info >> |
|
| Thursday, July 22, 2021 |
|
|
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced the donation of cash and supplies valued at RMB10 million to support Henan for flood relief and preventing epidemic. more info >> |
|
|
中国生物制药捐资捐物人民币1,000万元驰援河南抗灾防疫 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）宣布捐资捐物人民币1,000万元驰援河南抗灾防疫。 more info >> |
|
|
中國生物製藥捐資捐物人民幣1,000萬元馳援河南抗災防疫 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）宣佈捐資捐物人民幣1,000萬元馳援河南抗災防疫。 more info >> |
|
| Monday, May 24, 2021 |
|
|
中国生物制药2021年首季归属于母公司持有者应占盈利飙升118.5%至人民币19.14亿元 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2021年3月31日止三个月之未经审核财务业绩。 more info >> |
|
|
中國生物製藥2021年首季歸屬於母公司持有者應佔盈利飆升118.5%至人民幣19.14億元 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2021年3月31日止三個月之未經審核財務業績。 more info >> |
|
|
Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021. more info >> |
|
| Tuesday, March 23, 2021 |
|
|
中国生物制药2020年度纯利逆势增至人民币27.7亿元 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2020年12月31日止12个月之经审核财务业绩。 more info >> |
|
|
中國生物製藥2020年度純利逆勢增至人民幣27.7億元 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2020年12月31日止12個月之經審核財務業績。 more info >> |
|
|
Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited annual results for the year ended 31 December 2020. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通、プライバシーに配慮した見守りにより介護従事者などの負荷軽減を実現する「ミリ波レーダ見守りシステム」を提供開始
Jun 16, 2025 10:20: JST
|
|
|
Future of Uncrewed Airpower on Display at Paris Air Show
Jun 16, 2025 00:00 HKT/SGT
|
|
|
無人空中力量的未來在巴黎航展上亮相
Jun 16, 2025 00:00 HKT/SGT
|
|
|
調味品龍頭來襲！海天味業啟動港股招股
Jun 13, 2025 23:14 HKT/SGT
|
|
|
调味品龙头来袭！海天味业启动港股招股
Jun 13, 2025 23:02 HKT/SGT
|
|
|
SAP商業AI持續釋放數據價值 驅動企業韌性增長
Jun 13, 2025 22:52 HKT/SGT
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Annual Results
Jun 13, 2025 22:49 JST
|
|
|
達豐設備服務有限公司公佈2024/25全年業績
Jun 13, 2025 21:38 HKT/SGT
|
|
|
达丰设备服务有限公司公布2024/25全年业绩
Jun 13, 2025 21:34 HKT/SGT
|
|
|
Yee Hop Holdings (1662.HK) Subsidiary APEL Launches Microfactory in Collaboration with HKPC
Jun 13, 2025 21:38 JST
|
|
|
義合控股(1662.HK)附屬APEL與生產力局攜手打造智能微工廠正式投產
Jun 13, 2025 20:20 HKT/SGT
|
|
|
义合控股(1662.HK)附属APEL与生产力局携手打造智能微工厂正式投产
Jun 13, 2025 19:42 HKT/SGT
|
|
|
Jacobson Pharma Announces FY2025 Annual Results
Jun 13, 2025 20:16 JST
|
|
|
雅各臣公佈二零二五財年全年業績 持續經營業務溢利飈升43.1％至3.0億港元
Jun 13, 2025 19:06 HKT/SGT
|
|
|
Desert Mirage or Musical Revolution? ESCAPE Records' Secret Vault Opens, Revealing a Hidden Sonic Sanctuary
Jun 13, 2025 19:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
